Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations

European Journal of Pediatrics

Volumn 157, Issue 3, 1998, Pages 208-214

  Schmitt, H J ^a,c   Zepp, F ^a   Muschenborn S ^a   Sumenicht G ^a   Schuind, A ^a   Beutel, K ^a   Knuf, M ^a   Bock, H L ^b   Bogaerts, H ^b   Clemens, R ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Acellular pertussis; Diphtheria; Haemophilus influenzae type b; PRP tetanus; Vaccination

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; TETANUS TOXOID;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG MIXTURE; FEMALE; FEVER; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOGENICITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NORMAL HUMAN; PERTUSSIS; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; TETANUS;

ANALYSIS OF VARIANCE; ANTIBODIES, BACTERIAL; CHI-SQUARE DISTRIBUTION; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; PROSPECTIVE STUDIES; TETANUS; TETANUS TOXOID; VACCINES, CONJUGATE; WHOOPING COUGH;

EID: 15144361318     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050797     Document Type: Article

References (19)

1. Booy R, Aitken SJM, Taylor S, Tudor-Williams G, Macfarlane A, Moxon ER, Ashworth LAE, Mayon-White RT, Griffiths H, Chapel HM (1992) Immunogenicity of combined diphtheria, tetanus and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 339:507-510
2. Decker M, Edwards K, Bradley R, Palmer P (1992) Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 2:184-189
3. Eskola J, Käyhty H, Takala AK, Peltola H, Rönnberg PR, Kela E, Pekkanen E, McVerry PH, Mäkelä PH (1990) A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 323:1381-1387
4. Eskola J, Ölander RM, Hovi T, Litmanen L, Peltola S, Käyhty H (1996) Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 348:1688-1692
5. Ferrecio C, Clemens J, Avendano A, Horwitz I, Flores C, Avila L, Cayazzo M, Fritzell B, Cadoz M, Levine M (1991) The clinical and immunogenic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoid-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 10:764-771
6. Granoff DM, Holmes SJ, Osterholm MT, Mcugh JE, Lucas AH, Anderson EL, Belshe RB, Jacobs JL, Medley F, Murphy TV (1993) Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 168:663-671
7. Käyhty H (1994) Difficulties in establishing a serologieal correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 22:397-402
8. Madlon-Kay DF, Harper PG (1994) Too many shots? Parent, nurse and physician altitudes toward multiple simultaneous childhood vaccinations. Arch Fam Med 3:610-613
9. Melville-Smith ME, Balfour ME (1988) Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of enzyme-linked immunosorbant assay with the toxin neutralization test. J Med Microbiol 25:279-283
10. Melville-Smith ME, Seagroatt VA, Watkins JT (1983) A comparison of enzyme linked immunosorbant assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 11:137-144
11. Mulholland EK, Ahonkhai VI, Greenwood AM, Jonas LC, Lukacs LJ, Mink CM, Staub JM, Todd J, Vella PP, Greenwood BM (1993) Safety and immunogenicity of Haemophilus influenzae type b-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. Pediatr Infect Dis J 12:632-637
12. Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B (1993) Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? Can Med Assoc J 149:1105-1112
13. Schmitt HJ, Wirsing von König CH, Neiss A Bogaerts H, Bock HL, Schulte-Wissermann H, Gahr M, Schult R, Folkens JU, Rauh W, Clemens R (1996) Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275:37-41
14. Schmitt HJ, Beutel K, Schuind A, Knuf M, Wagner S, Müschenborn S, Bogaerts H, Bock HL, Clemens R (1997) Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus and tricomponent acellular pertussis vaccine in healthy infants at 14-28 months of age. J Pediatrics 130:616-623
15. Schmitt HJ, Schuind A, Knuf M, Beutel K, Schulte-Wissermann H, Gahr M, Schult R, Folkens J, Rauh W, Bogaerts H, Bock HL, Clemens R (1996) Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22505 infants. J Pediatrics 129:695-701
16. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT (1990) Natural history of pertussis antibody in the infant and the effect of vaccine response. J Infect Dis 161:487-492
17. Watemberg N, Dagan R, Arbelli Y, Belmaker I, Morag A, Hesrel L, Fritzell B, Bajard A, Peyron L (1991) Safety and immunogenicity of Haemophilus type b tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 10:758-761
18. Wiersbitzky S, Bock HL, Bruns R, Clemens R, Graul G, Köditz H, Padelt H, Schneeweis B, Meister W (1996) Verträglichkeit und Immunogenität einer 3-Komponentenazellulären Pertussis-Vakzine (DTPa) im Vergleich zur klassischen DTPg-Vakzine. Monatsschr Kinderheilkd 144:159-166
19. Zepp F, Schmitt HJ, Kaufhold A, Schuind A, Knuf M, Habermehl P, Bogaerts H, Slaoui M, Clemens R (1997) Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life; plain Haemophilus influenzea type b -PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 156:18-24